1. Altered Cholesterol Ester Cycle in Skin Fibroblasts from Patients with Alzheimer's Disease
- Author
-
Christina D. Orru, Anna Laurenzana, Maria Dolores Cannas, Claudia Mulas, Antonio Mitidieri Costanza, Sandra Dessì, Alessandra Pani, Cristina Cellai, Paolo La Colla, Pier Luigi Cocco, A. Bavazzano, Paolo Putzu, Giacomo Diaz, Francesco Paoletti, Fabrizio Angius, Antonella Mandas, Alessandra Mocali, and Claudia Abete
- Subjects
Male ,medicine.medical_specialty ,Genotype ,Caveolin 1 ,Biology ,Filipin ,chemistry.chemical_compound ,Apolipoproteins E ,Alzheimer Disease ,Internal medicine ,medicine ,Humans ,RNA, Messenger ,Receptor ,Neprilysin ,Aged ,Skin ,Aged, 80 and over ,Amyloid beta-Peptides ,Cholesterol ,General Neuroscience ,General Medicine ,Metabolism ,Fibroblasts ,Middle Aged ,Sterol ,Psychiatry and Mental health ,Clinical Psychology ,Endocrinology ,chemistry ,Case-Control Studies ,Imino Furanoses ,Female ,lipids (amino acids, peptides, and proteins) ,Cholesterol Esters ,Geriatrics and Gerontology ,Immunostaining ,Lipoprotein - Abstract
Intracellular cholesterol metabolism was reported to modulate amyloid-beta (Abeta) generation in Alzheimer's disease (AD). Results presented herein demonstrated that, like brain cells, cultured skin fibroblasts from AD patients contained more cholesterol esters than fibroblasts from healthy subjects. Particularly, Oil Red-O, Nile Red, and filipin staining highlighted higher levels of neutral lipids which responded to inhibitors of acyl-coenzyme A:cholesterol acyl-transferase (ACAT-1), associated with an increase in free cholesterol. ACAT-1 mRNA levels increased significantly in AD fibroblasts, whereas those of sterol regulatory element binding protein-2, neutral cholesterol ester hydrolase, and ATP-binding cassette transporter member 1 were markedly down-regulated. Instead, mRNA levels of low-density lipoprotein receptor, hydroxy-methyl-glutaryl-coenzyme A reductase, caveolin-1, and amyloid-beta protein precursor (AbetaPP) were virtually unchanged. Notably, mRNA levels of both beta-site AbetaPP-cleaving enzyme 1 (BACE1) and neprilysin were significantly down-regulated. An increase in Abeta(40) and Abeta(42) immunostaining and a decrease in BACE1 active form were also found in AD versus control fibroblasts. Altogether, these findings support the hypothesis that the derangement of cholesterol homeostasis is a systemic alteration involving central but also peripheral cells of AD patients, and point to cholesterol ester levels in AD fibroblasts as an additional metabolic hallmark useful in the laboratory and clinical practice.
- Published
- 2009
- Full Text
- View/download PDF